Filana Therapeutics
FLNA
25 hedge funds and large institutions have $5.58M invested in Filana Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
18% more capital invested
Capital invested by funds: $4.72M → $5.58M (+$861K)
4% more funds holding
Funds holding: 24 → 25 (+1)
0.96% less ownership
Funds ownership: 33.26% → 32.3% (-0.96%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3.29M |
| 2 |
First Eagle Investment Management
New York
|
+$1.19M |
| 3 |
Renaissance Technologies
New York
|
+$354K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$87.3K |
| 5 |
VF
Virtu Financial
New York
|
+$70.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$124K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49K |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$28K |
| 4 |
Bank of New York Mellon
New York
|
-$26.4K |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$23K |
FLNA Hedge Fund Activity: Q3 2018 in Review
25 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2018, worth a combined $5.58M — up 18% from $4.72M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FLNA positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $3.29M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $124K sold.
- 25 institutional investors held Filana Therapeutics (FLNA) as of Q3 2018, up from 24 in Q2 2018.
- Funds reported $5.58M of Filana Therapeutics stock for Q3 2018, up 18% quarter-over-quarter.
- 6 funds opened new Filana Therapeutics positions in Q3 2018 and 5 closed out, a net change of +1 holder.
- The largest Filana Therapeutics buyer in Q3 2018 was Armistice Capital, an estimated $3.29M added.
- The largest Filana Therapeutics seller in Q3 2018 was Dimensional Fund Advisors, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2018.